Literature DB >> 24833735

Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.

Martin-Paul Agbaga1, Beatrice M Tam2, Jenny S Wong2, Lee Ling Yang2, Robert E Anderson3, Orson L Moritz2.   

Abstract

PURPOSE: Autosomal dominant Stargardt macular dystrophy caused by mutations in the Elongation of Very Long Chain fatty acids (ELOVL4) gene results in macular degeneration, leading to early childhood blindness. Transgenic mice and pigs expressing mutant ELOVL4 develop progressive photoreceptor degeneration. The mechanism by which these mutations cause macular degeneration remains unclear, but have been hypothesized to involve the loss of an ER-retention dilysine motif located in the extreme C-terminus. Dominant negative mechanisms and reduction in retinal polyunsaturated fatty acids also have been suggested. To understand the molecular mechanisms involved in disease progression in vivo, we addressed the hypothesis that the disease-linked C-terminal truncation mutant of ELOVL4 exerts a dominant negative effect on wild-type (WT) ELOVL4, altering its subcellular localization and function, which subsequently induces retinal degeneration and loss of vision.
METHODS: We generated transgenic Xenopus laevis that overexpress HA-tagged murine ELOVL4 variants in rod photoreceptors.
RESULTS: Tagged or untagged WT ELOVL4 localized primarily to inner segments. However, the mutant protein lacking the dilysine motif was mislocalized to post-Golgi compartments and outer segment disks. Coexpression of mutant and WT ELOVL4 in rods did not result in mislocalization of the WT protein to outer segments or in the formation of aggregates. Full-length HA-tagged ELOVL4 lacking the dilysine motif (K308R/K310R) necessary for targeting the WT ELOVL4 protein to the endoplasmic reticulum was similarly mislocalized to outer segments.
CONCLUSIONS: We propose that expression and outer segment mislocalization of the disease-linked 5-base-pair deletion mutant ELOVL4 protein alters photoreceptor structure and function, which subsequently results in retinal degeneration, and suggest three possible mechanisms by which mutant ELOVL4 may induce retinal degeneration in STGD3. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  autosomal dominant Stargardt-like macular dystrophy (STGD3); elongation of very long chain fatty acids-4 (ELOVL4); photoreceptor outer segment; retinal degeneration

Mesh:

Substances:

Year:  2014        PMID: 24833735      PMCID: PMC4059079          DOI: 10.1167/iovs.13-13099

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  56 in total

1.  A method for generating transgenic frog embryos.

Authors:  E Amaya; K L Kroll
Journal:  Methods Mol Biol       Date:  1999

2.  Anti-rhodopsin monoclonal antibodies of defined specificity: characterization and application.

Authors:  G Adamus; Z S Zam; A Arendt; K Palczewski; J H McDowell; P A Hargrave
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

3.  Differential immunogold-dextran labeling of bovine and frog rod and cone cells using monoclonal antibodies against bovine rhodopsin.

Authors:  D Hicks; R S Molday
Journal:  Exp Eye Res       Date:  1986-01       Impact factor: 3.467

4.  The stop transfer sequence of the human UDP-glucuronosyltransferase 1A determines localization to the endoplasmic reticulum by both static retention and retrieval mechanisms.

Authors:  Lydia Barré; Jacques Magdalou; Patrick Netter; Sylvie Fournel-Gigleux; Mohamed Ouzzine
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

5.  Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA.

Authors:  D Deretic; S Schmerl; P A Hargrave; A Arendt; J H McDowell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Generation of transgenic X. laevis models of retinal degeneration.

Authors:  Beatrice M Tam; Christine C-L Lai; Zusheng Zong; Orson L Moritz
Journal:  Methods Mol Biol       Date:  2013

7.  Heterologous expression of photoreceptor peripherin/rds and Rom-1 in COS-1 cells: assembly, interactions, and localization of multisubunit complexes.

Authors:  A F Goldberg; O L Moritz; R S Molday
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

8.  An outer segment localization signal at the C terminus of the photoreceptor-specific retinol dehydrogenase.

Authors:  Wenqin Luo; Nicholas Marsh-Armstrong; Amir Rattner; Jeremy Nathans
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

9.  Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275.

Authors:  A Chedid; C L Mendenhall; T E Moritz; S W French; T S Chen; T R Morgan; G A Roselle; B A Nemchausky; C H Tamburro; E R Schiff
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

10.  Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum.

Authors:  M R Jackson; T Nilsson; P A Peterson
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  11 in total

Review 1.  Photoreceptors at a glance.

Authors:  Robert S Molday; Orson L Moritz
Journal:  J Cell Sci       Date:  2015-11-15       Impact factor: 5.285

2.  Defective phagosome motility and degradation in cell nonautonomous RPE pathogenesis of a dominant macular degeneration.

Authors:  Julian Esteve-Rudd; Roni A Hazim; Tanja Diemer; Antonio E Paniagua; Stefanie Volland; Ankita Umapathy; David S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  Mouse Models of Stargardt 3 Dominant Macular Degeneration.

Authors:  Peter Barabas; Aruna Gorusupudi; Paul S Bernstein; David Krizaj
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers.

Authors:  Aruna Gorusupudi; Aihua Liu; Gregory S Hageman; Paul S Bernstein
Journal:  J Lipid Res       Date:  2016-01-13       Impact factor: 5.922

Review 5.  Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Aspects Med       Date:  2018-10-01

6.  Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival.

Authors:  Dennis S Rice; Jorgelina M Calandria; William C Gordon; Bokkyoo Jun; Yongdong Zhou; Claire M Gelfman; Songhua Li; Minghao Jin; Eric J Knott; Bo Chang; Alex Abuin; Tawfik Issa; David Potter; Kenneth A Platt; Nicolas G Bazan
Journal:  Nat Commun       Date:  2015-03-04       Impact factor: 14.919

7.  Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.

Authors:  Christian Schori; Martin-Paul Agbaga; Richard S Brush; Radha Ayyagari; Christian Grimm; Marijana Samardzija
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

8.  Photoreceptor-induced RPE phagolysosomal maturation defects in Stargardt-like Maculopathy (STGD3).

Authors:  Camille Dejos; Sharee Kuny; Woo Hyun Han; Heather Capel; Hélène Lemieux; Yves Sauvé
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

9.  Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity.

Authors:  Bokkyoo Jun; Pranab K Mukherjee; Aram Asatryan; Marie-Audrey Kautzmann; Jessica Heap; William C Gordon; Surjyadipta Bhattacharjee; Rong Yang; Nicos A Petasis; Nicolas G Bazan
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

10.  Genetic identification and molecular modeling characterization reveal a novel PROM1 mutation in Stargardt4-like macular dystrophy.

Authors:  Saber Imani; Jingliang Cheng; Marzieh Dehghan Shasaltaneh; Chunli Wei; Lisha Yang; Shangyi Fu; Hui Zou; Md Asaduzzaman Khan; Xianqin Zhang; Hanchun Chen; Dianzheng Zhang; Chengxia Duan; Hongbin Lv; Yumei Li; Rui Chen; Junjiang Fu
Journal:  Oncotarget       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.